These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19334501)

  • 1. [Unsolved problems of enteropathy induced by nonsteroidal anti-inflammatory drugs].
    Murav'ev IuV; Lebedeva VV
    Ter Arkh; 2009; 81(2):90-3. PubMed ID: 19334501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enteropathy induced by nonsteroid anti-inflammatory drugs].
    Karateev AE; Nasonova VA
    Ter Arkh; 2004; 76(2):79-82. PubMed ID: 15106423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastropathy induced by nonsteroidal anti-inflammatory drugs (Part II)].
    Nasonov EL; Karateev AE
    Klin Med (Mosk); 2000; 78(4):4-9. PubMed ID: 10833880
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive therapy with H2 blockers in patients using steroids and nonsteroidal anti-inflammatory drugs].
    Abramovich D; Scapa E; Broide E; Eshchar J
    Harefuah; 1994 Mar; 126(5):271-3. PubMed ID: 7910573
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonsteroidal anti-inflammatory agents and gastrointestinal pathology].
    Lanas AI
    Gastroenterol Hepatol; 1995 Mar; 18(3):142-52. PubMed ID: 7621292
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects.
    Eliakim R; Rachmilewitz D
    Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage.
    McCormack PM
    Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941
    [No Abstract]   [Full Text] [Related]  

  • 9. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
    Sangha S; Oviedo JA
    Am J Gastroenterol; 2003 May; 98(5):1203-4; author reply 1204. PubMed ID: 12809852
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Fries JF
    N Engl J Med; 1999 Oct; 341(18):1397-8; author reply 1398-9. PubMed ID: 10577092
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drug-induced gastrointestinal damage. Current insights into patient management. Proceedings of a symposium. June 13, 1987, Washington, D.C.
    Am J Med; 1988 Feb; 84(2A):1-52. PubMed ID: 3348237
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs].
    Shiokawa Y; Nobunaga M; Saito T; Asaki S; Ogawa N
    Ryumachi; 1991 Feb; 31(1):96-111. PubMed ID: 1858000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastrointestinal complications of non-steroid anti-inflammatory drugs (NSAID): problems to be solved. Rheumatologist's expert opinion].
    Nasonov EL; Karateev AE
    Eksp Klin Gastroenterol; 2006; (2):6-9. PubMed ID: 16866255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of lesions caused by non-steroidal anti-inflammatory agents].
    De Angelis C; Rizzetto M; Pera A
    Minerva Gastroenterol Dietol; 1992; 38(1):27-40. PubMed ID: 1520751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Side effects of treatment with non-steroidal antiinflammatory agents and ways of their corrections].
    Grebneva LS; Nasonova SV; Tsvetkov LI
    Klin Med (Mosk); 1997; 75(5):42-5. PubMed ID: 9235408
    [No Abstract]   [Full Text] [Related]  

  • 16. [The gastrointestinal risk of antiplatelet agents and nonsteroidal anti-inflammatory agents. A report of the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG) and the American Heart Association (AHA)].
    Recenti Prog Med; 2009 May; 100(5):277-8. PubMed ID: 19772220
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage.
    Lisotti A; Grenci C; Caponi A; Roda E
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):323-9. PubMed ID: 19047972
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of vascular thrombosis and risk of gastrointestinal complications].
    Karateev AE; Nasonov EL
    Ter Arkh; 2007; 79(5):84-9. PubMed ID: 17672083
    [No Abstract]   [Full Text] [Related]  

  • 19. Ulcers from NSAIDs can be prevented.
    Health News; 2004 Mar; 10(3):11. PubMed ID: 15017941
    [No Abstract]   [Full Text] [Related]  

  • 20. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.